Microbiology
-
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2
This article has 19 authors:Reviewed by ScreenIT
-
Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without
This article has 7 authors:Reviewed by ScreenIT
-
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
This article has 11 authors:Reviewed by ScreenIT
-
Lopinavir-ritonavir is not an effective inhibitor of the main protease activity of SARS-CoV-2 in vitro
This article has 7 authors:Reviewed by ScreenIT
-
Elucidating the Antiviral Mechanism of Different MARCH Factors
This article has 6 authors:Reviewed by ScreenIT
-
Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro
This article has 7 authors:Reviewed by ScreenIT
-
Effect of mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion function
This article has 10 authors:Reviewed by ScreenIT
-
A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters
This article has 19 authors:Reviewed by ScreenIT
-
An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
This article has 10 authors:Reviewed by ScreenIT
-
The SARS-CoV-2 Spike mutation D614G increases entry fitness across a range of ACE2 levels, directly outcompetes the wild type, and is preferentially incorporated into trimers
This article has 3 authors:Reviewed by ScreenIT